4.5 Article

DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

C1q-Binding Antibodies in Kidney Transplantation

Lorraine C. Racusen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Urology & Nephrology

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation

Jennifer M. DeVos et al.

KIDNEY INTERNATIONAL (2012)

Article Surgery

Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation

T. B. Dunn et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2011)

Article Urology & Nephrology

Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection

Pamela M. Kimball et al.

KIDNEY INTERNATIONAL (2011)

Article Urology & Nephrology

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

Carmen Lefaucheur et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Surgery

Identifying Specific Causes of Kidney Allograft Loss

Z. M. El-Zoghby et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Review Surgery

Humoral theory of transplantation

PI Terasaki

AMERICAN JOURNAL OF TRANSPLANTATION (2003)

Review Surgery

T-cell allorecognition and transplant rejection: A summary and update

PS Heeger

AMERICAN JOURNAL OF TRANSPLANTATION (2003)